Endothelium-targeted pharmacotherapeutics for the treatment of stroke

Gary Danton, Brant D. Watson, Ricardo Prado, W. Dalton Dietrich

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The pathophysiology of stroke in humans is much more complex than what is typically studied in animal models. Embolic stroke models are more complex than pure ischemia models, but are more representative of human disease and may be particularly useful in the study of new therapeutic strategies. Vascular damage is a prominent feature of embolic stroke, and may be a useful therapeutic target. Serotonin antagonists, adenosine-regulating agents, free radical scavengers, matrix metalloproteinase inhibitors, and HMG-CoA reductase inhibitors are all potentially valuable agents in treating vascular damage after stroke. These agents facilitate decreased infarction volume, hemorrhage, and improved cerebral blood flow.

Original languageEnglish
Pages (from-to)896-904
Number of pages9
JournalCurrent Opinion in Investigational Drugs
Volume3
Issue number6
StatePublished - Jun 1 2002

Fingerprint

Endothelium
Stroke
Blood Vessels
Cerebrovascular Circulation
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Serotonin Antagonists
Free Radical Scavengers
Matrix Metalloproteinase Inhibitors
Adenosine
Infarction
Ischemia
Animal Models
Hemorrhage
Therapeutics

Keywords

  • Animal model
  • Cerebrovascular disorder
  • Endothelium
  • Vascular pharmacotherapy

ASJC Scopus subject areas

  • Pharmacology

Cite this

Endothelium-targeted pharmacotherapeutics for the treatment of stroke. / Danton, Gary; Watson, Brant D.; Prado, Ricardo; Dalton Dietrich, W.

In: Current Opinion in Investigational Drugs, Vol. 3, No. 6, 01.06.2002, p. 896-904.

Research output: Contribution to journalArticle

@article{8cae9bb8503e4573b0fbec91fc6baf84,
title = "Endothelium-targeted pharmacotherapeutics for the treatment of stroke",
abstract = "The pathophysiology of stroke in humans is much more complex than what is typically studied in animal models. Embolic stroke models are more complex than pure ischemia models, but are more representative of human disease and may be particularly useful in the study of new therapeutic strategies. Vascular damage is a prominent feature of embolic stroke, and may be a useful therapeutic target. Serotonin antagonists, adenosine-regulating agents, free radical scavengers, matrix metalloproteinase inhibitors, and HMG-CoA reductase inhibitors are all potentially valuable agents in treating vascular damage after stroke. These agents facilitate decreased infarction volume, hemorrhage, and improved cerebral blood flow.",
keywords = "Animal model, Cerebrovascular disorder, Endothelium, Vascular pharmacotherapy",
author = "Gary Danton and Watson, {Brant D.} and Ricardo Prado and {Dalton Dietrich}, W.",
year = "2002",
month = "6",
day = "1",
language = "English",
volume = "3",
pages = "896--904",
journal = "Expert Opinion on Investigational Drugs",
issn = "1354-3784",
publisher = "Taylor and Francis Ltd.",
number = "6",

}

TY - JOUR

T1 - Endothelium-targeted pharmacotherapeutics for the treatment of stroke

AU - Danton, Gary

AU - Watson, Brant D.

AU - Prado, Ricardo

AU - Dalton Dietrich, W.

PY - 2002/6/1

Y1 - 2002/6/1

N2 - The pathophysiology of stroke in humans is much more complex than what is typically studied in animal models. Embolic stroke models are more complex than pure ischemia models, but are more representative of human disease and may be particularly useful in the study of new therapeutic strategies. Vascular damage is a prominent feature of embolic stroke, and may be a useful therapeutic target. Serotonin antagonists, adenosine-regulating agents, free radical scavengers, matrix metalloproteinase inhibitors, and HMG-CoA reductase inhibitors are all potentially valuable agents in treating vascular damage after stroke. These agents facilitate decreased infarction volume, hemorrhage, and improved cerebral blood flow.

AB - The pathophysiology of stroke in humans is much more complex than what is typically studied in animal models. Embolic stroke models are more complex than pure ischemia models, but are more representative of human disease and may be particularly useful in the study of new therapeutic strategies. Vascular damage is a prominent feature of embolic stroke, and may be a useful therapeutic target. Serotonin antagonists, adenosine-regulating agents, free radical scavengers, matrix metalloproteinase inhibitors, and HMG-CoA reductase inhibitors are all potentially valuable agents in treating vascular damage after stroke. These agents facilitate decreased infarction volume, hemorrhage, and improved cerebral blood flow.

KW - Animal model

KW - Cerebrovascular disorder

KW - Endothelium

KW - Vascular pharmacotherapy

UR - http://www.scopus.com/inward/record.url?scp=0036628395&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036628395&partnerID=8YFLogxK

M3 - Article

C2 - 12137409

AN - SCOPUS:0036628395

VL - 3

SP - 896

EP - 904

JO - Expert Opinion on Investigational Drugs

JF - Expert Opinion on Investigational Drugs

SN - 1354-3784

IS - 6

ER -